Tempus AI TEM expects full-year 2025 revenues of $1.25 billion (up from the previous $1.24 billion guidance), which represents approximately 80% annual growth. The company also expects adjusted EBITDA ...

Tempus AITEM reached an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus ...

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity ...

Key Takeaways Ashok Leyland is a strong player in the auto sector, with a stock’s market cap of ₹73,457 crore and a 52-week ...